Health News (Reuters)

Drug reduces dyskinesia, 'off' times in Parkinson's patients

(Reuters Health) - An experimental extended-release version of the drug amantadine can reduce the duration of the involuntary dancing-like movements seen in people whose long-term use of levodopa has kept their Parkinson’s disease under control.

ISS pressures Mylan ahead of shareholder vote

(Reuters) - Influential proxy firm ISS on Monday turned up the heat on Mylan NV, advising its institutional clients to voice their dissatisfaction with the generic drugmaker's board of directors and its chairman's pay package at its June 22 shareholder meeting.

Supreme Court speeds copycat biologic drugs to market

WASHINGTON (Reuters) - The U.S. Supreme Court on Monday cut the time it will take for copycat versions of biologic drugs to get to the market in a pivotal ruling about an expensive class of medicines that can yield billions of dollars in sales for drug companies.

Premature babies often catch up to peers in school: study

(Reuters) - A study following more than 1.3 million premature babies born in Florida found that two-thirds of those born at only 23 or 24 weeks were ready for kindergarten on time, and almost 2 percent of those infants later achieved gifted status in school.

FDA rejects Coherus' biosimilar for Amgen's Neulasta

(Reuters) - Coherus BioSciences Inc said on Monday the U.S. Food and Drug Administration (FDA) denied the approval of its biosimilar for Amgen Inc's blockbuster treatment, Neulasta, which fights infections in cancer patients.

Chi-Med steps closer to Chinese pharma first with drug filing

LONDON (Reuters) - Hutchison China MediTech, the Shanghai-based drugmaker listed in London, is a step closer to winning approval for a modern drug developed in a Chinese lab with the submission of its cancer medicine fruquintinib to China's drug watchdog.

Sanofi-Regeneron's Praluent cuts cholesterol in Odyssey trials

PARIS (Reuters) - France's Sanofi and partner Regeneron Pharmaceuticals said on Sunday their anti-cholesterol drug Praluent recorded positive results in its first dedicated studies involving patients with diabetes and high cholesterol.

Roche CEO still optimistic on new breast cancer drug

VIENNA (Reuters) - Roche is convinced a new breast cancer drug will have a significant role in treating the disease despite recent trial results that disappointed analysts, the Swiss drugmaker's chief executive said in an interview published on Sunday.

Drinking in pregnancy tied to subtle changes in babies’ faces

(Reuters Health) - Women who drink even a little bit of alcohol during pregnancy may be more likely than other mothers to have babies with slight facial abnormalities that have been linked to developmental problems, a recent study suggests.

Tanzanian child victims of witchcraft attacks get new limbs

NEW YORK (Reuters) - Four Tanzanian children with albinism who lost limbs, fingers, and teeth in superstition-driven attacks made their way home this week after receiving prosthetics - and a dose of confidence - in the United States.

AbbVie must pay $15 million in Depakote birth-defect trial: jury

(Reuters) - A federal jury on Friday awarded $15 million to a 10-year-old boy whose mother blamed his birth defect on AbbVie Inc's bipolar disorder drug Depakote that she took while pregnant, in the latest trial among hundreds of lawsuits over the product.

Walking their dogs keeps elderly active

(Reuters Health) - Senior citizens who live with dogs appear to meet internationally recognized exercise goals just by walking them, a new study suggests.

Polio outbreak in Syria poses vaccination dilemma for WHO

GENEVA (Reuters) - Vaccinating too few children in Syria against polio because the six-year-old war there makes it difficult to reach them risks causing more cases in the future, the World Health Organization (WHO) said on Friday, posing a dilemma after a recent outbreak.

Mars recalls some chocolates due to likely Salmonella presence

(Reuters) - Confectioner Mars Inc, owner of the Mars and M&M brands, said on Friday that it had voluntarily recalled some products sold under the Galaxy brand in the UK and Ireland as it detected the possible presence of Salmonella in the ingredients.

Delaware governor signs first state abortion rights law under Trump

(Reuters) - Delaware's governor has signed into law a bill that ensures abortion remains legal in the state, in the first such move in the country since President Donald Trump was elected on a pledge to overturn Roe v. Wade, the 1973 landmark Supreme Court decision that protects a woman's right to abortion.

Medical costs of bike crashes on the rise

(Reuters Health) - Over the last two decades, the number of people injured in bicycle accidents in the U.S. has been rising and the cost of each crash has also gone up, according to a recent study.

Singapore confirms two new Zika virus cases

SINGAPORE (Reuters) - Singapore on Friday confirmed two cases of locally transmitted infections of the mosquito-borne Zika virus, bringing the total number of reported cases in the city-state this year to eight.